Artificial Intelligence and Telehealth: Challenges and Innovations in Health Tech
Artificial Intelligence in Health Tech
Artificial intelligence is rapidly reshaping the landscape of health tech. Eli Lilly has recently appointed Thomas Fuchs as its first chief AI officer, a notable step for the pharmaceutical giant. Fuchs previously directed the Hasso Plattner Institute for Digital Health at Mount Sinai in New York, where he significantly contributed to advancements in digital health.
Telehealth Challenges
Simultaneously, telehealth is facing DEA troubles related to regulation and access, emphasizing the urgent need for policy evolution to support these technological advancements. As healthcare systems adapt, the involvement of AI continues to grow, opening avenues for enhanced patient care.
FDA's Perspective on AI
The FDA's thinking on AI in clinical trials indicates a shift towards integrating innovative technologies into traditional healthcare settings. The ongoing integration of artificial intelligence not only enhances clinical practices but also addresses regulatory challenges posed by rapid technological changes.
- AI reshaping healthcare delivery.
- Importance of innovation in health tech.
- Challenges faced in telehealth settings.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.